Similarly, Jenkins et al. reported higher soluble TNF receptor (sTNFR)- 2 and IL-6 levels associated with decreased gray matter volume in specific regions in eight breast cancer patients who underwent chemotherapy during the study [26]. The gene discussed is IL6; the disease is breast carcinoma.